In this study, we have demonstrated that the regulatory mechanisms associated with modulating levels of O-GlcNAc-cycling enzymes according to cellular O-GlcNAcylation status appear to be different for OGA and OGT in lung cancer cells. The gene discussed is OGA; the disease is lung carcinoma.